Compound 1 (SNS-314) is a potent and selective Aurora kinase inhibitor that is currently in clinical trials in patients with advanced solid tumors. This communication describes the synthesis of prodrug derivatives of 1 with improved aqueous solubility profiles. In particular, phosphonooxymethyl-derived prodrug 2g has significantly enhanced solubility and is converted to the biologically active parent (1) following iv as well as po administration to rodents.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2009.01.043 | DOI Listing |
Publication Analysis
Top Keywords
aurora kinase
8
kinase inhibitor
8
water-soluble prodrugs
4
prodrugs aurora
4
inhibitor compound
4
compound sns-314
4
sns-314 potent
4
potent selective
4
selective aurora
4
inhibitor currently
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!